Notice of Participation of NIEHS in PAR-21-248 "Pediatric Immune System – Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)"
Notice Number:
NOT-ES-21-011

Key Dates

Release Date:

July 30, 2021

Related Announcements

PAR-21-248 - Pediatric Immune System – Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)

Issued by

National Institute of Environmental Health Sciences (NIEHS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Environmental Health Sciences (NIEHS) is participating, effective immediately, in PAR-21-248 "Pediatric Immune System – Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)".

The following text (emphasized in italic) has been updated to reflect the participation of NIEHS in this Funding Opportunity Announcement (FOA).

Part 1. Overview Information

Components of Participating Organizations

National Institute of Environmental Health Sciences (NIEHS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.113

Part 2. Section VII. Agency Contacts

Scientific/Research Contact

Anika Dzierlenga, PhD
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 984-287-3125
Email: [email protected]

Mike Humble, PhD
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 984-287-3272
Email: Humble@niehs.nih.gov

Financial/Grants Management Contact

Jenny Greer
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 984-287-3332
Email: [email protected]

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Anika Dzierlenga, PhD
National Institute of Environmental Health Sciences (NIEHS)
Telephone: (984) 287-3125
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices